Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

582
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
582
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

240
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
240
Tonsillitis II: Management01:26

Tonsillitis II: Management

429
This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
429
Impression Management Techniques I: Managing Appearances01:29

Impression Management Techniques I: Managing Appearances

218
Appearance is a multidimensional aspect of self-presentation that encompasses observable attributes such as clothing, grooming, speech, and nonverbal behavior. These elements are often strategically managed to align with socially constructed expectations in different settings. For instance, individuals tailor their appearance during job interviews, social gatherings, or athletic events to meet the perceived norms of those environments.Contextual Adaptation and Social SignalsThe research...
218
Managing Impressions01:19

Managing Impressions

172
Impression management encompasses individuals' deliberate efforts to shape how others perceive them during social interactions. This behavior is often employed to conform to social norms, secure approval, or pursue specific goals. While it involves selective self-presentation, it is not necessarily deceptive; individuals frequently present authentic aspects of themselves that align with situational demands.Common strategies include:Ingratiation: where individuals use flattery or agreeableness...
172
Management of Insomnia01:19

Management of Insomnia

641
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
641

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Publisher Correction: Probiotic Supplementation and Bone Health Parameters in Adults: A Systematic Review and Meta-Analysis.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Health-related quality of life instruments for older persons with osteoporosis: a WHO-BOHEG systematic review of measurement properties for use in clinical trials and routine practice.

Age and ageing·2026
Same author

Albumin-adjusted ("corrected") calcium should no longer be reported: a position statement from the Joint IOF Working Group and IFCC Committee on Bone Metabolism and EFLM Committee on CKD.

Clinical chemistry and laboratory medicine·2026
Same author

Expert consensus on hyaluronic acid injections for knee osteoarthritis: a patient-centered approach.

Aging clinical and experimental research·2026
Same author

"Build better bones": development, launch, and future directions of a multilingual, user-centered website for osteoporosis management.

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·2026
Same author

Recommendations from the European interdisciplinary council on ageing on physical activity and diet for mental health conditions in older adults.

Aging clinical and experimental research·2026

Related Experiment Video

Updated: Feb 2, 2026

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
07:20

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

1.1K

Postmenopausal osteoporosis: Assessment and management.

René Rizzoli1

  • 1Service of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, 1211 Geneva 14, Switzerland.

Best Practice & Research. Clinical Endocrinology & Metabolism
|November 20, 2018
PubMed
Summary

Osteoporosis fracture prevention involves optimal nutrition, exercise, and medications. Pharmacological treatments like bisphosphonates and teriparatide effectively reduce fracture risk in high-risk patients.

Keywords:
agingbisphosphonatesdenosumabfracturemalnutritionteriparatide

More Related Videos

Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
06:59

Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model

Published on: September 8, 2023

3.5K
Author Spotlight: Exploring the Impact of Lingnan Fire-Needle Therapy in Osteoporosis Intervention
03:56

Author Spotlight: Exploring the Impact of Lingnan Fire-Needle Therapy in Osteoporosis Intervention

Published on: April 26, 2024

1.3K

Related Experiment Videos

Last Updated: Feb 2, 2026

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice
07:20

Author Spotlight: Integrating Traditional Chinese Medicine with Modern Pharmacology and Genomics for Assessing Postmenopausal Osteoporosis in Mice

Published on: August 23, 2024

1.1K
Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
06:59

Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model

Published on: September 8, 2023

3.5K
Author Spotlight: Exploring the Impact of Lingnan Fire-Needle Therapy in Osteoporosis Intervention
03:56

Author Spotlight: Exploring the Impact of Lingnan Fire-Needle Therapy in Osteoporosis Intervention

Published on: April 26, 2024

1.3K

Area of Science:

  • Gerontology
  • Orthopedics
  • Pharmacology

Background:

  • Osteoporosis significantly elevates fracture risk, leading to increased mortality and reduced quality of life.
  • Individuals with a prior fracture face a substantially higher risk of subsequent fractures.
  • Effective fracture prevention strategies are crucial for managing this condition.

Purpose of the Study:

  • To review the evidence for pharmacological interventions in fracture prevention.
  • To highlight the efficacy of treatments in reducing vertebral and non-vertebral fracture risk.
  • To emphasize the importance of early intervention in high-risk patients.

Main Methods:

  • Review of randomized controlled trials focusing on anti-fracture efficacy.
  • Analysis of data from studies in postmenopausal women with fractures as the primary outcome.
  • Evaluation of treatments including bone resorption inhibitors and bone formation stimulators.

Main Results:

  • Pharmacological interventions, including bisphosphonates, denosumab, and teriparatide, demonstrably reduce fracture risk.
  • A significant reduction in vertebral fracture risk is observable within one year of initiating therapy.
  • These treatments are effective for both vertebral and non-vertebral fracture prevention.

Conclusions:

  • Pharmacological treatments are essential components of fracture prevention strategies.
  • Early initiation of therapy can lead to rapid reductions in fracture risk.
  • Comprehensive management includes lifestyle factors alongside medical interventions.